Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Poupon

Showing results (101-110 of 263) with videos related to

Pageof 27
Sort By:
Gastroenterology|January 1, 1994
Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinomaS Hillaire, V Barbu, E Boucher, et al.
The American Journal of Gastroenterology|November 30, 2000
Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activityJ Gozlan, I Nion, O Chazouillères, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1980
[Severe hepato-cellular insufficiency and renal insufficiency in a 66-year-old woman]R Poupon, E S Zafrani, M T Chaumette, et al.
Digestive Diseases and Sciences|December 1, 1996
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA)O Chazouillères, P Marteau, M Haniche, et al.
Annales De Medecine Interne|April 1, 1978
[Angio-immunoblastic lymphadenopathy and hepatitis B virus]F Darnis, R Poupon, P D'Escatha, et al.
Gastroenterologie Clinique Et Biologique|November 1, 1982
[Arsenic and copper in chronic liver diseases]Y Calmus, R Poupon, M B Brijnen, et al.
Gastroenterologie Clinique Et Biologique|August 1, 1984
[Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial]J C Barbare, F Ballet, J Petit, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Drug-induced liver injury. Twelfth updated edition of the bibliographic database of liver injuries and related drugs]M Biour, R Poupon, J D Grangé, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[Drug-induced hepatotoxicity. Eleventh update of the bibliographic database on liver injuries and responsible drugs]M Biour, R Poupon, J D Grangé, et al.
Gastroenterologie Clinique Et Biologique|March 1, 1982
[Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?]F Ballet, J C Barbare, J Petit, et al.
Pageof 27

Showing results (101-110 of 263) with videos related to

Sort By:
Pageof 27
Gastroenterology|January 1, 1994
Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinomaS Hillaire, V Barbu, E Boucher, et al.
The American Journal of Gastroenterology|November 30, 2000
Soluble Fas is increased in serum of patients with primary biliary cirrhosis, but is not a useful marker for disease activityJ Gozlan, I Nion, O Chazouillères, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1980
[Severe hepato-cellular insufficiency and renal insufficiency in a 66-year-old woman]R Poupon, E S Zafrani, M T Chaumette, et al.
Digestive Diseases and Sciences|December 1, 1996
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA)O Chazouillères, P Marteau, M Haniche, et al.
Annales De Medecine Interne|April 1, 1978
[Angio-immunoblastic lymphadenopathy and hepatitis B virus]F Darnis, R Poupon, P D'Escatha, et al.
Gastroenterologie Clinique Et Biologique|November 1, 1982
[Arsenic and copper in chronic liver diseases]Y Calmus, R Poupon, M B Brijnen, et al.
Gastroenterologie Clinique Et Biologique|August 1, 1984
[Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial]J C Barbare, F Ballet, J Petit, et al.
Gastroenterologie Clinique Et Biologique|January 22, 2000
[Drug-induced liver injury. Twelfth updated edition of the bibliographic database of liver injuries and related drugs]M Biour, R Poupon, J D Grangé, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[Drug-induced hepatotoxicity. Eleventh update of the bibliographic database on liver injuries and responsible drugs]M Biour, R Poupon, J D Grangé, et al.
Gastroenterologie Clinique Et Biologique|March 1, 1982
[Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?]F Ballet, J C Barbare, J Petit, et al.
Pageof 27